Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-04-13 23:23 (1879 d 14:54 ago) – Posting: # 18680
Views: 1,956


❝ Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT

I did a bunch of them a few years back but ours were NDAs (505b2s, ODTs vs reg tablets). Tablet on tongue, subject can't chew but can "suck" (you know, the small movement of your tongue like when you swallow something) on the tablet. After 10 or 30 seconds (don't remember details) check mouth. Once everything is disappear, then we give water...

Complete thread:

UA Flag
 Admin contact
22,617 posts in 4,740 threads, 1,611 registered users;
23 visitors (0 registered, 23 guests [including 13 identified bots]).
Forum time: 14:18 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz